Titan Pharmaceuticals Announces Fourth Quarter and Year End 2013 Financial

Titan Pharmaceuticals Announces Fourth Quarter and Year End 2013 Financial
Probuphine is an investigational subdermal implant designed to deliver continuous, around-the-clock blood levels of buprenorphine for six months following a single treatment, and to simplify patient compliance and retention. … Titan has been issued …
Read more on SYS-CON Media (press release)